CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Total Common Shares	Total Common Shares PurePenn and Solevo Wellness	Multiple Voting Shares	Subordinate Voting Shares	Subordinate Voting Shares PurePenn and Solevo Wellness	Additional Paid-in- Capital	Accumulated Earnings (Deficit)	Non- Controlling Interest
Beginning Balance (in shares) at Dec. 31, 2021		180,504,172		51,916,999	128,587,173
Beginning Balance at Dec. 31, 2021	$ 2,147,373						$ 2,008,100	$ 137,721	$ 1,552
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	18,124						18,124
Shares issued for cash - warrant exercise (in shares)		1,428,262			1,428,262
Shares issued for cash - warrant exercises	19,238						19,238
Subordinate Voting Shares issued under share compensation plans (in shares)		239,828			239,828
Subordinate Voting Shares issued under share compensation plans	156						156
Tax withholding related to net share settlements of equity awards (in shares)		(47,801)			(47,801)
Tax withholding related to net share settlements of equity awards	(615)						(615)
Conversion of Multiple Voting Shares to Subordinate Voting Shares (in shares)				(25,690,613)	25,690,613
Shares issued for PurePenn, LLC, Pioneer Leasing & Consulting LLC, and Solevo Wellness West Virginia, LLC earnout (in shares)			3,626,295			3,626,295
Release of escrow shares (in shares)		236,756			236,756
Distribution payable for acquisition of variable interest entity	(5,500)							(5,500)
Distributions to subsidiary non-controlling interest	(50)								(50)
Divestment of variable interest entity	110								110
Measurement period adjustment - Harvest Health & Recreation, Inc.	1,595								1,595
Net loss	(252,727)							(246,064)	(6,663)
Ending Balance (in shares) at Dec. 31, 2022		185,987,512		26,226,386	159,761,126
Ending Balance at Dec. 31, 2022	1,927,704						2,045,003	(113,843)	(3,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	10,575						10,575
Subordinate Voting Shares issued under share compensation plans (in shares)		334,611			334,611
Tax withholding related to net share settlements of equity awards (in shares)		(86,305)			(86,305)
Tax withholding related to net share settlements of equity awards	(466)						(466)
Distributions to subsidiary non-controlling interest	(50)								(50)
Consideration for purchase of variable interest entity	1,643						1,643
Deconsolidation of variable interest entity	2,219						(1,643)		3,862
Divestment of variable interest entity	124								124
Net loss	(533,136)							(526,796)	(6,340)
Ending Balance (in shares) at Dec. 31, 2023		186,235,818		26,226,386	160,009,432
Ending Balance at Dec. 31, 2023	1,408,613						2,055,112	(640,639)	(5,860)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	20,202						20,202
Subordinate Voting Shares issued under share compensation plans (in shares)		4,471,472			4,471,472
Subordinate Voting Shares issued under share compensation plans	210						210
Tax withholding related to net share settlements of equity awards (in shares)		(1,488,722)			(1,488,722)
Tax withholding related to net share settlements of equity awards	(14,751)						(14,751)
Conversion of Multiple Voting Shares to Subordinate Voting Shares (in shares)				(3,000,000)	3,000,000
Distributions to subsidiary non-controlling interest	(1,081)								(1,081)
Redeemed non-controlling interest, former mezzanine equity	1,096						(1,504)		2,600
Subordinate Voting Shares issued pursuant to redemption of non-controlling interest (in shares)		1,787,372			1,787,372
Subordinate Voting Shares issued pursuant to full redemption of non-controlling interests	1,904						1,904
Consolidated VIE settlement transaction	(6,585)						(4,141)		(2,444)
Net loss	(160,577)							(155,105)	(5,472)
Ending Balance (in shares) at Dec. 31, 2024		191,005,940		23,226,386	167,779,554
Ending Balance at Dec. 31, 2024	$ 1,249,031						$ 2,057,032	$ (795,744)	$ (12,257)